1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pneumonia Diagnostic Revenue
1.4 Market by Type
1.4.1 Global Pneumonia Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Streptococcus-based
1.4.3 Legionella-based
1.4.4 Chlamydophila-based
1.4.5 Viral Pneumonia-based
1.4.6 Mycoplasma Pneumonia-based
1.5 Market by Application
1.5.1 Global Pneumonia Diagnostic Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Diagnostic Centres
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pneumonia Diagnostic Market Perspective (2015-2026)
2.2 Global Pneumonia Diagnostic Growth Trends by Regions
2.2.1 Pneumonia Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pneumonia Diagnostic Historic Market Share by Regions (2015-2020)
2.2.3 Pneumonia Diagnostic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pneumonia Diagnostic Market Growth Strategy
2.3.6 Primary Interviews with Key Pneumonia Diagnostic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pneumonia Diagnostic Players by Market Size
3.1.1 Global Top Pneumonia Diagnostic Players by Revenue (2015-2020)
3.1.2 Global Pneumonia Diagnostic Revenue Market Share by Players (2015-2020)
3.1.3 Global Pneumonia Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pneumonia Diagnostic Market Concentration Ratio
3.2.1 Global Pneumonia Diagnostic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pneumonia Diagnostic Revenue in 2019
3.3 Pneumonia Diagnostic Key Players Head office and Area Served
3.4 Key Players Pneumonia Diagnostic Product Solution and Service
3.5 Date of Enter into Pneumonia Diagnostic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pneumonia Diagnostic Historic Market Size by Type (2015-2020)
4.2 Global Pneumonia Diagnostic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pneumonia Diagnostic Market Size by Application (2015-2020)
5.2 Global Pneumonia Diagnostic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pneumonia Diagnostic Market Size (2015-2020)
6.2 Pneumonia Diagnostic Key Players in North America (2019-2020)
6.3 North America Pneumonia Diagnostic Market Size by Type (2015-2020)
6.4 North America Pneumonia Diagnostic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pneumonia Diagnostic Market Size (2015-2020)
7.2 Pneumonia Diagnostic Key Players in Europe (2019-2020)
7.3 Europe Pneumonia Diagnostic Market Size by Type (2015-2020)
7.4 Europe Pneumonia Diagnostic Market Size by Application (2015-2020)
8 China
8.1 China Pneumonia Diagnostic Market Size (2015-2020)
8.2 Pneumonia Diagnostic Key Players in China (2019-2020)
8.3 China Pneumonia Diagnostic Market Size by Type (2015-2020)
8.4 China Pneumonia Diagnostic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pneumonia Diagnostic Market Size (2015-2020)
9.2 Pneumonia Diagnostic Key Players in Japan (2019-2020)
9.3 Japan Pneumonia Diagnostic Market Size by Type (2015-2020)
9.4 Japan Pneumonia Diagnostic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pneumonia Diagnostic Market Size (2015-2020)
10.2 Pneumonia Diagnostic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pneumonia Diagnostic Market Size by Type (2015-2020)
10.4 Southeast Asia Pneumonia Diagnostic Market Size by Application (2015-2020)
11 India
11.1 India Pneumonia Diagnostic Market Size (2015-2020)
11.2 Pneumonia Diagnostic Key Players in India (2019-2020)
11.3 India Pneumonia Diagnostic Market Size by Type (2015-2020)
11.4 India Pneumonia Diagnostic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pneumonia Diagnostic Market Size (2015-2020)
12.2 Pneumonia Diagnostic Key Players in Central & South America (2019-2020)
12.3 Central & South America Pneumonia Diagnostic Market Size by Type (2015-2020)
12.4 Central & South America Pneumonia Diagnostic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Pneumonia Diagnostic Introduction
13.1.4 Abbott Revenue in Pneumonia Diagnostic Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Glaxo Smith Kline
13.2.1 Glaxo Smith Kline Company Details
13.2.2 Glaxo Smith Kline Business Overview
13.2.3 Glaxo Smith Kline Pneumonia Diagnostic Introduction
13.2.4 Glaxo Smith Kline Revenue in Pneumonia Diagnostic Business (2015-2020)
13.2.5 Glaxo Smith Kline Recent Development
13.3 Affymetrix
13.3.1 Affymetrix Company Details
13.3.2 Affymetrix Business Overview
13.3.3 Affymetrix Pneumonia Diagnostic Introduction
13.3.4 Affymetrix Revenue in Pneumonia Diagnostic Business (2015-2020)
13.3.5 Affymetrix Recent Development
13.4 Becton Dickinson
13.4.1 Becton Dickinson Company Details
13.4.2 Becton Dickinson Business Overview
13.4.3 Becton Dickinson Pneumonia Diagnostic Introduction
13.4.4 Becton Dickinson Revenue in Pneumonia Diagnostic Business (2015-2020)
13.4.5 Becton Dickinson Recent Development
13.5 BioMerieux
13.5.1 BioMerieux Company Details
13.5.2 BioMerieux Business Overview
13.5.3 BioMerieux Pneumonia Diagnostic Introduction
13.5.4 BioMerieux Revenue in Pneumonia Diagnostic Business (2015-2020)
13.5.5 BioMerieux Recent Development
13.6 Cepheid
13.6.1 Cepheid Company Details
13.6.2 Cepheid Business Overview
13.6.3 Cepheid Pneumonia Diagnostic Introduction
13.6.4 Cepheid Revenue in Pneumonia Diagnostic Business (2015-2020)
13.6.5 Cepheid Recent Development
13.7 Diamedix/Erba
13.7.1 Diamedix/Erba Company Details
13.7.2 Diamedix/Erba Business Overview
13.7.3 Diamedix/Erba Pneumonia Diagnostic Introduction
13.7.4 Diamedix/Erba Revenue in Pneumonia Diagnostic Business (2015-2020)
13.7.5 Diamedix/Erba Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Abbott、Glaxo Smith Kline、Affymetrix、Becton Dickinson、BioMerieux、Cepheid、Diamedix/Erba
【免責事項】
https://www.globalresearch.jp/disclaimer